Eli Lilly Corp. buy Guggenheim
Start price
20.06.25
/
50%
€662.90
Target price
20.06.26
€813.01
Performance (%)
0.41%
Price
30.07.25
€665.60
Summary
This prediction is currently active. Since the start of the prediction for Eli Lilly Corp. the price has only changed by 0.41%. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.945% | -1.945% |
| iShares Core DAX® | -1.184% | 0.861% |
| iShares Nasdaq 100 | 3.941% | 6.184% |
| iShares Nikkei 225® | -1.206% | -0.294% |
| iShares S&P 500 | 3.141% | 5.930% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
-1.07%
30.07.25
30.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-20.84%
30.07.25
30.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-5.26%
30.07.25
30.07.25